Steroid-based treatment may answer needs of pediatric EoE patients
A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in...
View ArticleInterferon-free combination therapy prevents recurrence of HCV after liver...
A 24-week course of sofosbuvir and ribavirin can eliminate hepatitis C virus (HCV) infection in two-thirds of patients who undergo liver transplantation, with positive consequences on their short- and...
View ArticleNew approach to preventing fibrosing strictures in IBD
A natural protein made by immune cells may limit fibrosis and scarring in colitis, according to research published in the inaugural issue of Cellular and Molecular Gastroenterology and Hepatology, the...
View ArticleDiscovery of new signaling intermediates provides clues to novel therapies in...
Signaling initiated by pancreatic digestive enzyme-producing (acinar) cells is essential to development of both pain and inflammation in pancreatitis, according to research published in the inaugural...
View ArticleResearch offers novel insight into Hirschsprung's disease
Defects in the protein Sox10, a transcription factor that regulates gene expression, may play a role in the development of post-operative GI dysfunction in Hirschsprung's disease patients, according to...
View ArticleTransoral fundoplication is an effective treatment for patients with GERD
Transoral fundoplication is an effective treatment for patients with gastroesophageal reflux disease (GERD), especially for patients with persistent regurgitation despite proton pump inhibitor (PPI)...
View ArticleSteroid therapy increases risk of blood clots five-fold in IBD patients
Compared with biologic therapy, corticosteroid (steroid) use is associated with a nearly five-fold increase of venous thromboembolism in inflammatory bowel disease (IBD) patients, according to a new...
View ArticleChronic narcotic use is high among kids with IBD
Chronic narcotic use is more than twice as prevalent in children with inflammatory bowel disease (IBD), compared with children without this disease, according to a new study published in Clinical...
View ArticleUnderstanding how the stomach responds to injury could help target therapy...
A better understanding of the stomach's immune response to Helicobater pylori (H. pylori) infection could lead to new therapies targeting damage in the stomach, report researchers in the March issue of...
View ArticlePatients with asymptomatic pancreatic cysts do not need constant surveillance
A new guideline from the American Gastroenterological Association (AGA) changes clinical practice by recommending longer surveillance periods for patients with asymptomatic pancreatic cysts and new...
View ArticleFemale IBD patients: Stay up-to-date on your cervical cancer screening
Women with inflammatory bowel disease (IBD) may be at increased risk of cervical dysplasia and cancer, according to a new study published in Clinical Gastroenterology and Hepatology, the official...
View ArticleLiver injury in NASH leads to a leaky gut
Non-alcoholic steatohepatitis (NASH), the more severe form of non-alcoholic fatty liver disease (NAFLD) that can progress to liver fibrosis and cirrhosis, is associated with leakiness of the intestinal...
View ArticleGastroenterology Special Issue confirms: You are what you eat
Patients are always interested in understanding what they should eat and how it will impact their health. Physicians are just as interested in advancing their understanding of the major health effects...
View ArticleNovel biomarkers may provide guide to personalized hepatitis C therapy
A simple blood test can be used to predict which chronic hepatitis C patients will respond to interferon-based therapy, according to a report in the May issue of Cellular and Molecular Gastroenterology...
View ArticleDrug prevents passage of HBV during pregnancy
The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), according to a study in the June issue of Clinical Gastroenterology and Hepatology, the official clinical...
View ArticleResearch may provide new targets for IBD therapies
Modifying the small white blood cells that protect against disease might help treat immune disorders, according to a study1 published in Cellular and Molecular Gastroenterology and Hepatology, the...
View ArticleSpouses and relatives of celiac disease patients at risk for autoimmune diseases
Both spouses and first-degree relatives of patients with celiac disease are at increased risk of nonceliac autoimmune disease, according to a study in the July issue of Clinical Gastroenterology and...
View ArticlePinaverium shows promising results for treatment of irritable bowel syndrome
Pinaverium offers quick and effective relief of irritable bowel syndrome (IBS) symptoms, according to clinical trial results published in Clinical Gastroenterology and Hepatology, the official clinical...
View ArticleResearchers identify genetic mutation causing lethal condition in infants
Newborn children born with a mutation in the Plasmalemma Vesicle Associated Protein (PLVAP) gene develop severe protein losing enteropathy, according to a case study1 published in Cellular and...
View ArticleWeight loss for a healthy liver
Weight loss through both lifestyle modification and bariatric surgery can significantly reduce features of nonalcoholic steatohepatitis (NASH), a disease characterized by fat in the liver, according to...
View Article